D
Teva Pharmaceutical Industries Limited TEVA
$16.33 -$0.13-0.79%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 4.40% 9.81% 8.47% 7.22% 6.16%
Total Other Revenue -- -- -- -- --
Total Revenue 4.40% 9.81% 8.47% 7.22% 6.16%
Cost of Revenue 3.40% 1.68% 0.34% 0.74% 3.13%
Gross Profit 5.48% 19.43% 18.25% 14.94% 9.62%
SG&A Expenses 5.80% 6.35% 4.69% 3.93% 1.51%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -175.00% -101.64% -83.58% -112.12% -80.65%
Total Operating Expenses 3.99% 2.64% 2.11% 1.59% 2.98%
Operating Income 6.07% 45.27% 40.63% 35.74% 21.04%
Income Before Tax -106.43% 77.27% 93.58% 66.65% 80.19%
Income Tax Expenses 11,350.00% 574.51% 174.66% 94.12% 99.07%
Earnings from Continuing Operations -218.02% 49.90% 69.35% 56.53% 75.34%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 471.43% 180.43% 206.19% 240.45% 5.66%
Net Income -192.68% 58.96% 80.72% 71.99% 77.10%
EBIT 6.07% 45.27% 40.63% 35.74% 21.04%
EBITDA 2.28% 27.27% 23.09% 18.98% 10.11%
EPS Basic -188.79% 59.79% 81.22% 72.20% 77.25%
Normalized Basic EPS 29.93% 86.62% 81.07% 67.79% 23.90%
EPS Diluted -181.76% 59.09% 80.58% 71.46% 76.58%
Normalized Diluted EPS 31.09% 86.42% 80.19% 66.91% 23.01%
Average Basic Shares Outstanding 1.01% 0.96% 0.92% 0.85% 0.86%
Average Diluted Shares Outstanding 0.33% 1.00% 1.41% 1.35% 1.35%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings